Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Tafluprost in Primary Open-Angle Glaucoma or Ocular Hypertension
2008-006718-10Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in open-angle glaucoma (OAG) and ocular hypertension comparing Travatan arm with Taflotan arm (2 arms). Primary endpoint: Intraocular pressure at 20:00 hours. Started Jul 2009; status: completed.
02
Drugs
travoprosttafluprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2008-006718-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006718-10.